Business Wire

Mary Kay Inc. Champions Business Excellence, Ethics and Social Responsibility in Direct Selling Sector and Beauty Industry, Reaps Rewards in Europe

Share

On May 22, the global beauty company announced Chairman and CEO David Holl is among the top ten most reputable chief executives in the world according to Reputation Institute’s 2019 CEO RepTrak® study. Reputation Institute, the world’s leading provider of reputation intelligence, measured the reputation of more than 140 global CEOs and canvassed more than 230,000 individual ratings among the informed public. The study was conducted in January and February of this year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190710005268/en/

Tara Eustace, President of the Mary Kay Europe Region. (Photo: Mary Kay Inc.)

Tara Eustace, President of the Mary Kay Europe Region. (Photo: Mary Kay Inc.)

According to Kylie Wright-Ford, CEO at Reputation Institute, acting responsibly, behaving ethically and caring about social issues are the most important drivers of CEO reputation. In fact, according to Reputation Institute’s findings, CEOs are more likely to be judged on ethics versus profit margins. In this way, the perception of CEOs and the companies they lead are directly correlated.

This meaningful recognition echoes the series of milestones reached by Mary Kay in Europe over the past months. In 2018 and 2019, Mary Kay's Europe Region earned over 90 product and industry awards and counting — a testament to Mary Kay’s mission to enrich women’s lives, offer science-driven products women love and a long-standing commitment to give back to the community.

“In a highly competitive environment, Mary Kay’s business values stand out around the world, and shine in Europe,” said Tara Eustace, President of the Mary Kay Europe Region. “Each of these awards materialize the truth of our commitment; they also provide Independent Beauty Consultants in Europe pride to celebrate with their customers and share product news and updates, while reinforcing confidence in the brand,” added Eustace.

Recent awards include:

Excellence in Direct Selling
Seldia, the European Direct Selling Association, recently recognized Mary Kay Europe as “Best Company of the Year” at its 2018 Astra Awards. In July 2019, Mary Kay Belarus received the “Direct Sales Cosmetic Company Number One Award” from the “Number One” annual national awards. In June 2019, Mary Kay Ukraine was recognized as “Number 1 Direct Selling Cosmetic Brand” in the “Favor of Success” survey. Mary Kay Spain has been the 2014, 2015, 2016 and 2017 “Number 1 Direct Selling Cosmetic Company” according to the Commercial Register data.

Excellence in Women’s Leadership
In April 2019, Mary Kay Russia’s General Manager, Alla Sokolova, received the "Manager of the Year Award” from Russian Business Guide's People of the Year, recognizing her contribution to the development of the Russian economy and entrepreneurship in Russia.

In 2016, 2017, and 2018, Mary Kay Spain's General Manager, Gema Aznar, was featured in YoDona magazine's annual “500 Most Influential Women in Spain” list highlighted in its special edition called “Female Power.”

Excellence in Women’s Entrepreneurship and Empowerment
On May 24, the “Secrets of Big Business with Mary Kay®” program created by Mary Kay Russia was recognized as the “2019 Best Social Project of Russia Award” in the “Social Entrepreneurship” category. In November 2018, Mary Kay Russia had already earned the “Woman Who Matters Award” rewarding women’s entrepreneurship for the “Secrets of Big Business with Mary Kay®” program. “Woman Who Matters” identifies the best initiatives, practices and programs of Russian companies aimed at women’s support.

Mary Kay Russia also received the “2018 Best Social Project of Russia Award” for its “Beauty of Confidence” campaign and Skin Care Labs. The Best Russian Social Project annual contest was held in May, with more than 70 companies submitting their social projects. The program was created to support the Russian government’s plans to strengthen social policies.

Mary Kay Belarus received a “2018 Brand of the Year” Silver Medal in the Social Responsibility category for its socially active position. The award was a result of the implementation of the “Beauty That Counts” program and the company's contribution to the development of women's entrepreneurship in Belarus.

Mary Kay UK received the “Company with Heart Award” at the 2018 UK Pride of Direct Selling Awards for their partnership with the Look Good, Feel Better charity. “The Company with Heart Award” is awarded to the company which has gone the extra mile to make a charitable impact through its philanthropic activities and community engagement work.

Excellence in Digital Training
Mary Kay was recognized in the “2019 Spring Omni Awards” with a coveted gold ranking in the Educational category for its innovative Link & Learn™ sales education system. The e-learning platform hosts a robust learning curriculum designed to amplify educational support for the independent sales force and increase their business success. It also connects Mary Kay Independent Beauty Consultants to a learning community based on content, accessibility and localization. Mary Kay’s Link & Learn was also awarded a “2018 Technology Excellence Award” from the Brandon Hall Group last January with a Bronze Medal in the category of Best Advance in Learning Management Technology for External Training.

Excellence in Digital & Printed Tools
In April, Mary Kay Russia’s MirrorMe App won the "2019 Best Corporate Media Award” in the "Client Media: Web Media” category. With the Mary Kay® MirrorMe mobile application, anyone can create beautiful makeup without any makeup tools.

Mary Kay Russia’s “Applause” magazine for Independent Beauty Consultants won two awards in 2018: the "Media Leader Award” in the category "Best Corporate Magazine" and the “Silver Threads Award” in the category “Best Corporate Edition.”

Excellence as an Employer
Mary Kay Spain and Mary Kay Poland earned the “2018 AON Best Employers Award,” recognizing organizations demonstrating excellence in the workplace.

Product Excellence
With more than 1,500 patents and a team of scientists dedicated to producing innovative products backed by proven results, Mary Kay® products garnered more than 40 awards in 2018 and already 22 in 2019. Among the products distinguished by the Beauty industry and consumers, Mary Kay TimeWise Miracle® 3D set, TimeWise Repair® Lifting Bio-Cellulose Mask, TimeWise® Vitamin C Activating Squares, and Oil-Free Eye Makeup Remover, were the most rewarded.

About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 55 years ago with three goals: offer rewarding opportunities for women, manufacture irresistible products and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to researching the science behind beauty and to manufacturing cutting-edge skin care, color cosmetics, fragrances and nutritional supplements. Through the Mary Kay Foundation℠, the company has awarded more than $78 million to cancer research and domestic violence shelters. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.

About Reputation Institute
Reputation Institute helps leaders at the world’s largest companies build credibility with the people that matter most to them by delivering data-driven insights about how they are truly perceived. We do this with RepTrak®, an unrivaled technology that provides actionable insights across industry, competitor, and company analysis. Past and present clients have included Whirlpool, Barnes & Noble,​The Estée Lauder Companies, ​JP Morgan Chase & Co., LEGO, P&G, Cisco, and Telefonica, among many others.

About Seldia
Seldia recognizes the outstanding achievements of organizations that demonstrate excellence in empowerment, entrepreneurship and a commitment to producing best-in-the-industry products. Representing 28 national direct selling associations and 20 member-companies throughout Europe, Seldia’s mission is to promote the interest of national direct selling associations and direct selling companies in the European footprint. “Best Company of the Year” recognizes the corporate member that best raises awareness of the direct selling method of distribution, promotes the method’s socio-economic benefits and demonstrates a strong commitment to supporting the mission of Seldia.

Contact information

Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease19.7.2019 17:59:00 CESTPress release

Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. OTEZLA, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behçet’s Disease, a rare, chronic, multisystem inflammatory disease that is difficult to treat. “Oral ulcers are a recurring and debilitating manifestation that affects nearly everyone living with Behçet’s Disease, and have an important negative impact on the quality of life for these patients,” said Yusuf Yazici, M.D., Clinical Associate Professor, Department of Medicine, New York University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA has the potential to be a needed treatment option for U.S. patients and their physicians, who

Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer19.7.2019 13:05:00 CESTPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA ® ) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019.1,2 The WHO’s Essential Medicines List is a core guidance document that helps countries prioritise critical health products that are recommended to be widely available and affordable throughout health systems.1 “The inclusion of abiraterone acetate in the WHO Essential Medicines List highlights the critical role that this treatment can play in improving the lives of patients living with mCRPC and their families,” said Dr. Joaquín Casariego, Janssen Therapeutic Area Lead Oncology for Europe, Middle East & Africa, Janssen-Cilag S.A. “I am proud that we are working hard to impact survival and quality of life by developing and providing innovative medicines which ar

Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis19.7.2019 12:30:00 CESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets. Novartis will receive an upfront payment and is eligible to receive up to an additional $291 million in potential milestone payments upon achievement of certain development and commercial milestones, as well as royalties on annual net sales. “Today’s announcement builds on Gilead’s heritage in antiviral research and development. We look forward to applying this expertise to advance the development of potential new treatments for viruses with limited therapeutic options,” said John McHutchison AO, MD, Gilead’s Chief Scientific Officer and Head of Research and Development. Gilead’s antiviral portfolio include

Schlumberger Announces Second-Quarter 2019 Results19.7.2019 11:00:00 CESTPress release

Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2019 Mar. 31, 2019 Jun. 30, 2018 Sequential Year-on-year Revenue $8,269 $7,879 $8,303 5% 0% Pretax segment operating income $968 $908 $1,094 7% -12% Pretax segment operating margin 11.7% 11.5% 13.2% 17 bps -148 bps Net income - GAAP basis $492 $421 $430 17% 14% Net income, excluding charges & credits* $492 $421 $594 17% -17% Diluted EPS - GAAP basis $0.35 $0.30 $0.31 17% 13% Diluted EPS, excluding charges & credits* $0.35 $0.30 $0.43 17% -19% North America revenue $2,801 $2,738 $3,139 2% -11% International revenue $5,463 $5,037 $5,065 8% 8% North America revenue, excluding Cameron $2,243 $2,178 $2,546 3% -12% International revenue, excluding Cameron $4,761 $4,469 $4,387 7% 9% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commente

Schlumberger Appoints Olivier Le Peuch as CEO19.7.2019 10:46:00 CESTPress release

Schlumberger Limited (NYSE: SLB) announced today that its Board of Directors has appointed Olivier Le Peuch as its Chief Executive Officer and member of the Schlumberger Board, effective August 1, 2019. Mr. Le Peuch succeeds Paal Kibsgaard, who will retire as Chief Executive Officer effective that same date. Also effective August 1, Mr. Kibsgaard will step down as Chairman of the Board and retire as a member of the Board of Directors. Mr. Kibsgaard will retire after more than 22 years of service to the Company, including eight years as CEO and four years as Chairman. Effective the same date, Mark G. Papa, a current non-independent director, will become non-executive Chairman of the Board. Peter Currie will continue to serve as the Board’s Lead Independent Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190719005161/en/ Olivier Le Peuch is appointed Chief Executive Officer and a member of the Schlumberger Board, effe

Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK19.7.2019 10:00:00 CESTPress release

Fluke Corp., the global leader in test and measurement instruments, has acquired Ismaning, Germany-based PRÜFTECHNIK, a market leader in precision laser shaft alignment, condition monitoring, and non-destructive testing. “Fluke’s acquisition of PRÜFTECHNIK reflects the growing importance our customers place on reliability systems to keep their equipment in optimum operating condition,” said Marc Tremblay, president of Fluke Corporation. “This business will help us usher in the next generation of solutions for our industrial customers.” Fluke Corporation For information on Fluke tools and applications, or to find the location of your nearest distributor, contact Fluke Corporation, P.O. Box 9090, Everett, WA USA 98206, call (800) 44-FLUKE (800-443-5853), fax (425) 446-5116, e-mail fluke-info@fluke.com or visit the Fluke Web site at http://www.fluke.com. About Fluke Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measu